Ishita Drugs & Industries Ltd
Ishita Drugs & Industries Ltd (ISHITADR) last traded at ₹75.2, a market capitalisation of ₹22.5 crore, on a P/E of 31.7. Over the past 52 weeks the stock has ranged between ₹66 and ₹90.8. Ishita Drugs & Industries Ltd last reported results for the quarter ended Jun 2026, with sales of ₹3.15 crore and net profit of ₹0.23 crore. Figures are as of 25 Aug 2026 and are not real time.
Ishita Drugs & Industries Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Ishita Drugs & Industries Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹3.15 cr, down 41.7% from ₹5.4 cr a year earlier. Net profit was ₹0.23 cr, down 23.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 3.27 | 4.13 | 4.56 | 5.4 | 3.07 | 3.14 | 3.06 | 3.15 |
| Expenses | 3.03 | 3.83 | 4.27 | 5.06 | 2.89 | 3 | 2.96 | 2.84 |
| Operating profit | 0.24 | 0.3 | 0.29 | 0.34 | 0.18 | 0.14 | 0.1 | 0.31 |
| OPM % | 7.34% | 7.26% | 6.36% | 6.30% | 5.86% | 4.46% | 3.27% | 9.84% |
| Other income | 0.05 | 0.07 | 0.16 | 0.09 | 0.07 | 0.1 | 0.22 | 0.04 |
| Interest | 0 | 0.02 | 0.04 | 0.02 | 0 | 0.02 | 0.02 | 0 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.05 |
| Profit before tax | 0.26 | 0.32 | 0.38 | 0.38 | 0.22 | 0.19 | 0.28 | 0.3 |
| Tax % | 23.08% | 25.00% | 23.68% | 23.68% | 36.36% | 21.05% | 35.71% | 23.33% |
| Net profit | 0.19 | 0.24 | 0.29 | 0.3 | 0.14 | 0.16 | 0.18 | 0.23 |
| EPS (₹) | 0.64 | 0.80 | 0.97 | 1.00 | 0.47 | 0.54 | 0.60 | 0.77 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Ishita Drugs & Industries Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 13.95 | 14.09 | 12.07 | 15.19 | 15 | 14.66 | 12.42 |
| Operating profit | 0.92 | 1.08 | 0.76 | 0.91 | 0.99 | 0.77 | 0.73 |
| OPM % | 6.59% | 7.67% | 6.30% | 5.99% | 6.60% | 5.25% | 5.88% |
| Net profit | 0.83 | 0.8 | 0.58 | 0.75 | 0.87 | 0.78 | 0.71 |
| EPS (₹) | 2.78 | 2.68 | 1.94 | 2.51 | 2.91 | 2.61 | 2.38 |
TTM is the trailing twelve months to the most recent quarter.
Ishita Drugs & Industries Ltd growth and returns
- 10 Years
- 8%
- 5 Years
- 1%
- 3 Years
- 7%
- TTM
- -28%
- 10 Years
- 19%
- 5 Years
- -1%
- 3 Years
- 10%
- TTM
- -30%
- 10 Years
- 16%
- 5 Years
- 12%
- 3 Years
- 2%
- 1 Year
- 1%
- 10 Years
- 7%
- 5 Years
- 8%
- 3 Years
- 8%
- Last Year
- 7%
Ishita Drugs & Industries Ltd shareholding pattern
Promoters held 50.04% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 49.80% | 49.85% | 49.91% | 49.92% | 49.96% | 50.04% | 50.04% | 50.04% |
| Public | 50.19% | 50.14% | 50.08% | 50.09% | 50.04% | 49.95% | 49.97% | 49.96% |
| No. of shareholders | 5,555 | 5,412 | 5,398 | 5,341 | 5,320 | 5,263 | 5,194 | 5,146 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Ishita Drugs & Industries Ltd corporate filings
- Outcome of the Board meeting held on 08th August, 2026.Board Meetingmedium impact
Cruxal's analysis: Ishita Drugs & Industries Limited reported a decline in revenue from operations to 3.15…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Ishita Drugs & Industries Ltd
Cruxal reads every Ishita Drugs & Industries Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.